Ipamorelin Research Products
High-purity ipamorelin research products provide laboratory investigators with a highly selective growth hormone secretagogue receptor (GHSR-1a) agonist. Synthesized to analytical standards in the USA, PX1 Research supplies lot-verified ipamorelin reagents designed exclusively for in vitro assays and preclinical animal models.
Quick answer
High-purity ipamorelin research products provide laboratory investigators with a highly selective growth hormone secretagogue receptor (GHSR-1a) agonist. Synthesized to analytical standards in the USA, PX1 Research supplies lot-verified ipamorelin reagents designed exclusively for in vitro assays and preclinical animal models.
Key takeaways
- [Ipamorelin](/research-peptides/ipamorelin) research products consist of high-purity, synthetic pentapeptides engineered specifically for laboratory investigation into growth hormone secretagogue receptor (GHSR-1a) signaling.
- [Ipamorelin](/research-peptides/ipamorelin) is classified structurally as a ghrelin peptidomimetic.
- Preclinical investigation into [ipamorelin](/research-peptides/ipamorelin) has focused extensively on its capacity to mimic natural, pulsatile growth hormone secretion patterns.
- A primary defining feature of [ipamorelin](/research-peptides/ipamorelin) in laboratory settings is its extreme selectivity for growth hormone release.
Direct Overview of Ipamorelin Research Products
Ipamorelin research products consist of high-purity, synthetic pentapeptides engineered specifically for laboratory investigation into growth hormone secretagogue receptor (GHSR-1a) signaling. Known for inducing selective, pulsatile growth hormone release without elevating plasma cortisol or prolactin levels, these compounds serve as critical reference reagents for in vitro receptor binding assays and preclinical physiological research.
As a synthetic pentapeptide with the sequence Aib-His-D-2Nal-D-Phe-Lys-NH2, ipamorelin represents one of the most selective growth hormone (GH) secretagogues evaluated in preclinical science. Researchers utilizing ipamorelin research products target its distinct binding properties to isolate GH release pathways without the confounding endocrinological variables introduced by less selective peptides. Every batch distributed by PX1 Research undergoes stringent multi-stage testing to ensure consistent molecular mass, precise sequence identity, and verified chemical purity for experimental rigor.
Molecular Structure and GHSR-1a Receptor Activation
Ipamorelin is classified structurally as a ghrelin peptidomimetic. It interacts directly with the growth hormone secretagogue receptor type 1a (GHSR-1a), a G-protein coupled receptor situated predominantly in the anterior pituitary gland and hypothalamus. Unlike native ghrelin or earlier synthetic secretagogues, ipamorelin's terminal modification and amino acid sequence allow high-affinity binding to GHSR-1a while minimizing secondary signal transduction cascades.
In vitro receptor binding assays indicate that upon binding GHSR-1a, ipamorelin triggers intracellular calcium mobilization via the phospholipase C (PLC) and inositol trisphosphate (IP3) signaling pathways. This intracellular calcium influx triggers the exocytosis of somatotroph storage vesicles, prompting the release of growth hormone into culture media or circulation in animal models. Because it does not stimulate the central adrenergic or stress axes, ipamorelin provides a clean, isolated mechanistic baseline for studying somatotroph response.
Preclinical Literature on Pulsatile Growth Hormone Release
Preclinical investigation into ipamorelin has focused extensively on its capacity to mimic natural, pulsatile growth hormone secretion patterns. In animal models, including rodent and non-human primate studies, administration of ipamorelin triggers a sharp, transient spike in circulating GH levels that closely mimics endogenous physiological pulses. This contrasts sharply with continuous GH elevation, which can induce receptor down-regulation and tissue desensitization.
Data from preclinical rodent models demonstrate that repeated exposure to ipamorelin maintains baseline receptor responsiveness without inducing rapid tachyphylaxis. Researchers exploring somatotroph kinetics frequently utilize ipamorelin alongside growth hormone-releasing hormone (GHRH) analogs to examine potential synergistic signaling pathways within pituitary cell cultures. Further mechanistic details regarding secretagogue interactions are available in the growth hormone secretagogue research library.
Selectivity Profile: Absence of Cortisol and Prolactin Stimulation
A primary defining feature of ipamorelin in laboratory settings is its extreme selectivity for growth hormone release. First-generation growth hormone secretagogues frequently stimulate the adrenocorticotropic hormone (ACTH) pathway and prolactin secretion alongside growth hormone. In contrast, in vitro assays and animal models consistently demonstrate that ipamorelin does not induce significant elevations in ACTH, plasma cortisol, or prolactin, even when evaluated at concentrations several times higher than its ED50 for GH release.
This absence of non-target hormone stimulation makes ipamorelin an exceptional control and test reagent in endocrinology experiments. When laboratory models require the isolation of GH-driven anabolic or metabolic pathways without the catabolic influences of cortisol or hyperprolactinemia, ipamorelin remains the primary research compound of choice. Detailed comparison data across different secretagogue classes can be reviewed in our CJC-1295 research guide.
Comparative Analysis: Ipamorelin vs. Related GH Secretagogues
When designing preclinical protocols, researchers must select secretagogues based on desired receptor selectivity, potency, and potential off-target effects. Ipamorelin is frequently evaluated alongside other growth hormone releasing peptides and hypothalamic analogs to establish baseline functional differences in somatotroph activation profiles.
In direct comparative preclinical studies, GHRP-6 demonstrates potent GH release but significantly increases appetite signaling via hypothalamic NPY pathways and raises plasma cortisol. Similarly, GHRP-2 exhibits high potency but triggers measurable spikes in both ACTH and prolactin levels. Non-peptide GH secretagogues like MK-677 offer extended half-lives but lack the transient, tight pulsatility of ipamorelin. Meanwhile, GHRH peptide mimetics like sermorelin research products act through the GHRH receptor rather than GHSR-1a, offering a complementary mechanism that researchers often combine with ipamorelin in dual-receptor co-stimulation assays.
Laboratory Handling, Reconstitution, and Buffer Compatibility
To ensure experimental reproducibility, researchers must adhere to precise handling protocols when reconstituting lyophilized ipamorelin. The compound is supplied as a sterile, lyophilized cake packaged under an inert atmosphere to prevent oxidative degradation. Lyophilized ipamorelin exhibits excellent solubility in aqueous solutions, including sterile bacteriostatic water, phosphate-buffered saline (PBS), and dilute acetic acid.
For standard in vitro application, reconstitution using sterile 0.9% sodium chloride or sterile water for injection is recommended. When preparing stock solutions for long-term cell culture studies, gentleness during solubilization is critical: water or buffer should be drawn slowly down the interior glass wall of the vial, followed by gentle swirling rather than vigorous vortexing. Aggressive mechanical agitation can cause shear stress, leading to peptide aggregation or secondary structure denaturing.
Storage Stability and Reagent Preservation
Maintaining chemical integrity across extended experimental timelines requires strict temperature and environmental controls. Lyophilized ipamorelin research products retain maximum stability when stored at -20°C to -80°C in a desiccated environment away from direct light exposure. Under these frozen, desiccated conditions, the un-reconstituted lyophilized powder remains stable for up to 24 months without significant degradation.
Once reconstituted into aqueous stock solutions, ipamorelin should be aliquoted into single-use polypropylene microcentrifuge tubes to prevent repeated freeze-thaw cycles. Reconstituted solution aliquots stored at -20°C maintain chemical stability for several months, while liquid solutions stored at standard refrigeration temperatures (2°C to 8°C) should be utilized within 21 to 28 days to minimize hydrolytic cleavage.
Analytical Quality Standards: HPLC, MS, and Endotoxin Control
Experimental integrity in cell culture and animal models depends fundamentally on compound purity and the absence of biological contaminants. Low-grade research compounds containing synthesis byproducts, truncated peptide sequences, or residual organic solvents can introduce unquantified variables that invalidate experimental data.
PX1 Research subjects every batch of ipamorelin to a rigorous analytical testing regime conducted by an independent ISO 17025 accredited laboratory. Analytical testing includes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm structural purity exceeding 99%, and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify precise molecular weight. Furthermore, all products undergo Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels fall strictly below <0.01 EU/mg, preventing unwanted inflammatory signaling in sensitive biological assays.
Sourcing Verified Research Peptides for USA Laboratories
Selecting a reliable supplier for laboratory reagents requires full transparency regarding synthesis location, quality control protocols, and lot traceability. PX1 Research manufactures all research compounds within cGMP-compliant facilities located in the USA, adhering to stringent chemical synthesis standards.
Every shipment from PX1 Research includes batch-specific Certificates of Analysis (COAs) detailing the HPLC chromatogram, mass spectra, and endotoxin assay results. Institutional buyers and academic investigators requiring bulk quantities or recurring order schedules can utilize the PX1 Research wholesale portal to access tailored institutional support. To explore our full range of analytical-grade compounds, visit the complete high-purity research peptides catalog.
Frequently Asked Questions
What is the intended use of ipamorelin research products?
Ipamorelin research products are intended strictly for laboratory research, in vitro cellular assays, and preclinical animal models. They are not intended for human consumption, medical diagnosis, or therapeutic applications.
What receptor does ipamorelin target in laboratory assays?
Ipamorelin acts as a selective agonist at the growth hormone secretagogue receptor type 1a (GHSR-1a), stimulating downstream intracellular calcium mobilization and pulsatile growth hormone release.
How does ipamorelin differ from GHRP-6 and GHRP-2 in preclinical research?
Unlike GHRP-6 and GHRP-2, which stimulate ACTH, cortisol, prolactin, and ghrelin-mediated appetite pathways, ipamorelin demonstrates high selectivity for GH release without elevating non-target pituitary or adrenal hormones.
What purity levels are provided with PX1 Research ipamorelin?
PX1 Research provides ipamorelin verified at >99% chemical purity via RP-HPLC and mass spectrometry. Each lot includes a downloadable, third-party ISO 17025 laboratory Certificate of Analysis.
What are the recommended storage conditions for lyophilized ipamorelin?
Lyophilized ipamorelin should be stored at -20°C to -80°C in a dry, dark environment. Upon reconstitution, liquid stock solutions should be stored at 2°C to 8°C for short-term use or aliquoted and frozen at -20°C for long-term storage.
What reconstitution solvents are compatible with ipamorelin research products?
Ipamorelin is readily soluble in sterile bacteriostatic water, 0.9% physiological saline, phosphate-buffered saline (PBS), and diluted acetic acid solutions depending on experimental buffer requirements.
What endotoxin standards apply to PX1 Research ipamorelin?
Every lot of ipamorelin undergoes LAL testing to ensure endotoxin levels remain below 0.01 EU/mg, preventing inflammatory interference in cell culture models.
Where are PX1 Research compounds synthesized and shipped from?
All PX1 Research compounds are synthesized in USA-based cGMP-compliant facilities and dispatched with same-day shipping (M–F) from distribution hubs in California and Arizona.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.